美股市场个股详情
IPHA Innate Pharma
- 1.830
- -0.045-2.40%
收盘价 11/04 16:00 (美东)
1.48亿总市值-4021市盈率TTM
1.940最高价1.800最低价2136股成交量1.940今开1.875昨收3960.95成交额0.00%换手率亏损市盈率(静)8095.08万总股本3.15052周最高4.74市净率1.01亿流通值1.70052周最低--股息TTM5525.35万流通股11.950历史最高--股息率TTM7.47%振幅1.700历史最低1.854平均价1股每手
关于Innate Pharma公司
Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。其方法是通过治疗性抗体和专有平台ANKET（基于抗体的NK细胞接合疗法）来利用先天免疫系统。公司的收入来自于与制药公司签订的研究、合作和许可协议所获得的款项。其产品管线包括lacutamab、monalizumab、IPH5201、IPH5301、IPH6101、IPH62、IPH6401和IPH6501。
公司介绍
公司代码IPHA
公司名称Innate Pharma
上市日期2019/10/17
发行价格5.50
成立日期1999
CEODr. Mondher Mahjoubi, M.D.
所属市场纳斯达克
员工数量179
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址117, Avenue de Luminy
城市Marseille
省份普罗旺斯-阿尔卑斯-蓝色海岸
国家法国
邮编13009
电话33-4-30-30-30-30
董事高管
- 姓名
- 职务
- 年薪
- Dr. Mondher Mahjoubi, M.D.
- Chairman of the Executive Board and Chief Executive Officer
- --
- Nicola Beltraminelli
- Vice President and Chief Development Officer
- --
- Frederic Lombard
- Chief Financial Officer
- --
- Sonia Quaratino
- Chief Medical Officer and Executive Vice President
- --
- Eric Vivier, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Claire de Saint Blanquat
- Vice President, Legal and Corporate Affairs
- --
- Yannis Morel, PhD
- Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development
- --
- Henry Wheeler
- Vice President, Investor Relations and Communications
- --
- Odile Laurent
- Vice President, Human Resources
- --
- Odile Belzunce
- Vice President, Compliance, IT and Portfolio Management
- --
- Irina Staatz-Granzer, PhD
- Vice Chairman of the Supervisory Board
- --
- Herve Brailly, PhD
- Chairman of the Supervisory Board
- --
- Dr. Veronique Chabernaud, M.D.
- Member of the Supervisory Board
- --
- Sally Bennett
- Member of the Supervisory Board
- --
- Olivier Martinez
- Member of the Supervisory Board
- --
- Gilles Brisson
- Member of the Supervisory Board
- --
- Professor Jean-Yves Blay, PhD
- Member of the Supervisory Board
- --
- Pascale Boissel
- Member of the Supervisory Board
- --
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据